| Detected | Trial | Change |
|---|---|---|
| 2026-07-24 | NCT07716852 Enzymax DuoBiotics for Irritable Bowel Syndrome |
Primary endpoint(s) modified |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-27 | NCT07729293 Pylori Duo for Adjunctive Treatment and Prevention of Recurrence of Helicobacter Pylori… | Not Yet Recruiting | |
| 2026-07-21 | NCT07716852 Enzymax DuoBiotics for Irritable Bowel Syndrome | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Not specified | |||
| NCT07716852 | Enzymax DuoBiotics for Irritable Bowel Syndrome | Irritable Bowel Syndrome | Not Yet Recruiting |
| NCT07729293 | Pylori Duo for Adjunctive Treatment and Prevention of Recurrence of Helicobacter Pylori… | Helicobacter Pylori Infection | Not Yet Recruiting |